Jun 2026 (Q2 FY26) — Aug 10, 2026
Nu Skin Q2 FY26 — Prysm iO Rollout Progresses, India Launch Delayed, and Profitability Focus
Read the full callNu Skin (NUS) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Nu Skin earnings: last reported Mon, 10 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 320 | −17.1% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -18.5 | −26.5 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -250 | −1282.8% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$4.97 −3.31% · −$0.17
Performance −53.5% 1Y
1Y: $10.69 on 17 Oct 2025 → $4.97. High $11.54 (16 Jan 2026), low $4.53 (30 Sept 2026).
- Previous close
- $5.14
- 52-week range
- $4.53 – $11.54
- One year
- −53.98%
Overview
- Symbol
- NUS
- Sector
- Consumer Staples
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Nu Skin earnings calls (NUS)
Financials
What the filings say
Net profit, year on year: −1283% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 430 | 446 | 364 | 386 | 364 | 370 | 321 | 320 |
| Operating profit | 18 | -53 | -10 | 31 | 22 | 23 | 4 | -59 |
| Operating margin | 4.2% | −11.9% | −2.7% | 8.0% | 5.9% | 6.3% | 1.3% | −18.5% |
| Other income | 2 | 1 | -28 | -1 | -2 | -1 | 3 | -1 |
| Interest | 7 | 6 | 3 | 3 | 4 | 4 | 4 | 3 |
| Profit before tax | 13 | -58 | 135 | 27 | 16 | 18 | 3 | -63 |
| Tax rate | 37.6% | 37.5% | 20.1% | 22.9% | −6.8% | 20.3% | 29.4% | −295.4% |
| Net profit | 8 | -36 | 108 | 21 | 17 | 14 | 2 | -250 |
| EPS ($ per share) | 0.17 | — | 2.16 | 0.43 | 0.35 | — | 0.04 | -5.14 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | 1,636 | 1,728 | 1,841 | 1,912 | 1,939 | 1,870 | 1,712 | 1,860 |
| Total liabilities | 913 | 894 | 1,063 | 994 | 924 | 987 | 817 | 600 |
| Fixed assets | 465 | 454 | 468 | 454 | 445 | 433 | 380 | 377 |
| Investments | 11 | 8 | 21 | 15 | 14 | 12 | 11 | 1 |
| Total assets | 1,694 | 1,769 | 1,957 | 1,906 | 1,821 | 1,809 | 1,469 | 1,405 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 203 | 178 | 379 | 142 | 108 | 119 | 112 | 80 |
| Cash from investing | -109 | -71 | -79 | -89 | -67 | -135 | -38 | 171 |
| Cash from financing | -117 | -155 | -245 | -105 | -100 | 11 | -133 | -202 |
| Net cash flow | -39 | -51 | 67 | -63 | -75 | -9 | -69 | 52 |
| Capital expenditure | -70 | -66 | -64 | -69 | -59 | -58 | -42 | -34 |
| Free cash flow | 132 | 112 | 315 | 73 | 49 | 60 | 70 | 46 |
Insider filings
41 filings between Nov 11, 2025 and Sep 9, 2026.
Open market
decisions to buy or sellPurchases
$52.9K
1 purchase by 1 insider
Sales
$99.5K
3 sales by 3 insiders
67% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 26
- Award — granted as compensation
- 11
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Hatchett Steven Keith | $52.9K | — | Nov 11, 2025 |
| WOODBURY EDWINA D | — | $41.1K | Jun 1, 2026 |
| Winett James M | — | $40.5K | Jun 2, 2026 |
| Nathanson Laura | — | $18.0K | May 11, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 9, 2026 | WOODBURY EDWINA D Director | Award | 22 | $107 |
| Jun 10, 2026 | WOODBURY EDWINA D Director | Award | 19 | $103 |
| Jun 2, 2026 | Winett James M Director | Sale 10b5-1 plan | 7,203 | $40.5K |
| Jun 1, 2026 | WOODBURY EDWINA D Director | Sale 10b5-1 plan | 7,203 | $41.1K |
| Jun 1, 2026 | Zorko Mark A Director | Award | 26,643 | $0 |
| Jun 1, 2026 | Nathanson Laura Director | Award | 26,643 | $0 |
| Jun 1, 2026 | Winett James M Director | Award 10b5-1 plan | 26,643 | $0 |
| Jun 1, 2026 | CAMPBELL DANIEL W Director | Award | 26,643 | $0 |
| Jun 1, 2026 | Battle Emma S. Director | Award | 26,643 | $0 |
| Jun 1, 2026 | WOODBURY EDWINA D Director | Award 10b5-1 plan | 26,643 | $0 |
| Jun 1, 2026 | Thomas Pisano R. Director | Award | 26,643 | $0 |
| May 11, 2026 | Nathanson Laura Director | Sale | 2,676 | $18.0K |
| Mar 11, 2026 | WOODBURY EDWINA D Director | Award | 14 | $102 |
| Mar 6, 2026 | Thomas James D Chief Financial Officer | Award | 114,706 | $0 |
| Mar 6, 2026 | Hatchett Steven Keith Chief Product Officer | Award | 77,941 | $0 |
| Mar 6, 2026 | Keisel Justin S EVP, President of Global Sales | Award | 47,059 | $0 |
| Mar 6, 2026 | Clark Chayce David EVP, COO and CLO | Award | 138,971 | $0 |
| Mar 6, 2026 | NAPIERSKI RYAN S President and CEO | Award | 282,353 | $0 |
| Feb 26, 2026 | Keisel Justin S EVP, President of Global Sales | Tax withheld | 13,687 | $118.1K |
| Feb 26, 2026 | NAPIERSKI RYAN S President and CEO | Tax withheld | 124,802 | $1.08M |
| Feb 26, 2026 | Thomas James D Chief Financial Officer | Tax withheld | 28,602 | $246.8K |
| Feb 26, 2026 | Clark Chayce David EVP and General Counsel | Tax withheld | 45,502 | $392.7K |
| Feb 26, 2026 | Hatchett Steven Keith Chief Product Officer | Tax withheld | 26,001 | $224.4K |
| Feb 15, 2026 | Thomas James D Chief Financial Officer | Tax withheld | 11,725 | $98.0K |
| Feb 15, 2026 | Clark Chayce David EVP and General Counsel | Tax withheld | 17,947 | $150.0K |
| Feb 15, 2026 | Hatchett Steven Keith Chief Product Officer | Tax withheld | 10,763 | $90.0K |
| Feb 15, 2026 | Keisel Justin S EVP, President of Global Sales | Tax withheld | 1,534 | $12.8K |
| Feb 15, 2026 | NAPIERSKI RYAN S President and CEO | Tax withheld | 49,037 | $409.9K |
| Feb 10, 2026 | Clark Chayce David EVP and General Counsel | Award | 15,667 | $0 |
| Feb 10, 2026 | NAPIERSKI RYAN S President and CEO | Award | 42,970 | $0 |
| Feb 10, 2026 | NAPIERSKI RYAN S President and CEO | Award | 206,988 | $0 |
| Feb 10, 2026 | Thomas James D Chief Financial Officer | Award | 9,847 | $0 |
| Feb 10, 2026 | Clark Chayce David EVP and General Counsel | Award | 75,466 | $0 |
| Feb 10, 2026 | Hatchett Steven Keith Chief Product Officer | Award | 8,952 | $0 |
| Feb 10, 2026 | Hatchett Steven Keith Chief Product Officer | Award | 43,124 | $0 |
| Feb 10, 2026 | Keisel Justin S EVP, President of Global Sales | Award | 2,910 | $0 |
| Feb 10, 2026 | Keisel Justin S EVP, President of Global Sales | Award | 34,500 | $0 |
| Feb 10, 2026 | Thomas James D Chief Financial Officer | Award | 47,436 | $0 |
| Dec 20, 2025 | Clark Chayce David EVP and General Counsel | Tax withheld | 9,049 | $92.9K |
| Dec 10, 2025 | WOODBURY EDWINA D Director | Award | 10 | $104 |
| Nov 11, 2025 | Hatchett Steven Keith Chief Product Officer | Purchase | 5,500 | $52.9K |
| Sep 10, 2025 | WOODBURY EDWINA D Director | Award | 9 | $104 |
| Sep 4, 2025 | Nathanson Laura Director | Sale | 6,489 | $79.3K |
| Sep 3, 2025 | Clark Chayce David EVP and General Counsel | Sale | 20,000 | $239.4K |
| Aug 29, 2025 | CAMPBELL DANIEL W Director | Sale | 9,046 | $109.6K |
| Aug 29, 2025 | CAMPBELL DANIEL W Director | Sale | 23,391 | $283.0K |
| Aug 1, 2025 | Thomas James D Chief Financial Officer | Tax withheld | 915 | $7.5K |
| Aug 1, 2025 | Clark Chayce David EVP and General Counsel | Tax withheld | 205 | $1.7K |
| Jun 11, 2025 | WOODBURY EDWINA D Director | Award | 13 | $105 |
| Jun 2, 2025 | Thomas Pisano R. Director | Award | 18,008 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for NU SKIN ENTERPRISES, INC.
Free account. Everything above stays public.
Write why you follow NU SKIN ENTERPRISES, INC. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading